Krishan A - Search Results

1

Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells".

Lampidis TJ, Kurtoglu M, Maher JC, Liu H, Krishan A, Sheft V, Szymanski S, Fokt I, Rudnicki WR, Ginalski K, Lesyng B, Priebe W. Lampidis TJ, et al. Among authors: krishan a. Cancer Chemother Pharmacol. 2006 Dec;58(6):725-34. doi: 10.1007/s00280-006-0207-8. Epub 2006 Mar 23. Cancer Chemother Pharmacol. 2006. PMID: 16555088

2

Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions.

Maher JC, Krishan A, Lampidis TJ. Maher JC, et al. Among authors: krishan a. Cancer Chemother Pharmacol. 2004 Feb;53(2):116-22. doi: 10.1007/s00280-003-0724-7. Epub 2003 Nov 7. Cancer Chemother Pharmacol. 2004. PMID: 14605866

3

Reversal of intrinsic resistance to adriamycin in normal cells by verapamil.

Lampidis TJ, Krishan A, Planas L, Tapiero H. Lampidis TJ, et al. Among authors: krishan a. Cancer Drug Deliv. 1986 Fall;3(4):251-9. doi: 10.1089/cdd.1986.3.251. Cancer Drug Deliv. 1986. PMID: 3567846

4

Reversal of resistance to rhodamine 123 in adriamycin-resistant Friend leukemia cells.

Lampidis TJ, Munck JN, Krishan A, Tapiero H. Lampidis TJ, et al. Among authors: krishan a. Cancer Res. 1985 Jun;45(6):2626-31. Cancer Res. 1985. PMID: 3986800

5

MDR-1 gene expression, anthracycline retention and cytotoxicity in human lung-tumor cells from refractory patients.

Ramachandran C, Sauerteig A, Sridhar KS, Thurer RJ, Krishan A. Ramachandran C, et al. Among authors: krishan a. Cancer Chemother Pharmacol. 1993;31(6):431-41. doi: 10.1007/BF00685031. Cancer Chemother Pharmacol. 1993. PMID: 8095859

6

Phase I and pharmacokinetics studies of prochlorperazine 2-h i.v. infusion as a doxorubicin-efflux blocker.

Sridhar KS, Krishan A, Samy TS, Duncan RC, Sauerteig A, McPhee GV, Auguste ME, Benedetto PW. Sridhar KS, et al. Among authors: krishan a. Cancer Chemother Pharmacol. 1994;34(5):377-84. doi: 10.1007/BF00685561. Cancer Chemother Pharmacol. 1994. PMID: 8070004 Clinical Trial.

7

Prochlorperazine as a doxorubicin-efflux blocker: phase I clinical and pharmacokinetics studies.

Sridhar KS, Krishan A, Samy TS, Sauerteig A, Wellham LL, McPhee G, Duncan RC, Anac SY, Ardalan B, Benedetto PW. Sridhar KS, et al. Among authors: krishan a. Cancer Chemother Pharmacol. 1993;31(6):423-30. doi: 10.1007/BF00685030. Cancer Chemother Pharmacol. 1993. PMID: 8453681 Clinical Trial.

8

A phase I study of 4'-0-tetrahydropyranyladriamycin. Clinical pharmacology and pharmacokinetics.

Sridhar KS, Samy TS, Agarwal RP, Duncan RC, Benedetto P, Krishan AG, Vogel CL, Feun LG, Savaraj NM, Richman SP, et al. Sridhar KS, et al. Among authors: krishan ag. Cancer. 1990 Nov 15;66(10):2082-91. doi: 10.1002/1097-0142(19901115)66:10<2082::aid-cncr2820661007>3.0.co;2-5. Cancer. 1990. PMID: 2224762 Clinical Trial.

9

Anthracycline-induced DNA breaks and resealing in doxorubicin-resistant murine leukemic P388 cells.

Maniar N, Krishan A, Israel M, Samy TS. Maniar N, et al. Among authors: krishan a. Biochem Pharmacol. 1988 May 1;37(9):1763-72. doi: 10.1016/0006-2952(88)90440-6. Biochem Pharmacol. 1988. PMID: 2837239

10

Anthracycline resistance in murine leukemic P388 cells. Role of drug efflux and glutathione related enzymes.

Nair S, Singh SV, Samy TS, Krishan A. Nair S, et al. Among authors: krishan a. Biochem Pharmacol. 1990 Feb 15;39(4):723-8. doi: 10.1016/0006-2952(90)90151-a. Biochem Pharmacol. 1990. PMID: 2306280 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters